Study of Sentinel Lymph Node Assessment Following Previous Surgical Biopsy for Early Breast Cancer
NCT ID: NCT00293865
Last Updated: 2016-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
203 participants
INTERVENTIONAL
2006-03-31
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients
NCT05703295
Sentinel Lymph Node Biopsy With or Without Para-Sentinel Lymph Node Dissection in Breast Cancer
NCT02651142
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer
NCT03255577
Surgical Trial to Evaluate the Impact of a Lymphoscintigraphy Prior to Sentinel Node Biopsy in Early Breast Cancer
NCT02481128
Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer
NCT00005821
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sentinel node
detection of the sentinel node in breast cancer
GAS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Previous conservative surgical biopsy
* Secondary pathological diagnosis of infiltrative cancer
* No clinically involved axillary node (N0)
* No previous neoadjuvant treatment
* Performance status European Cancer Conference (ECCO) Grade ≤ 1
* Patient's written informed consent to participate in the study according to French law
* Surgeon must have performed its learning curve
Exclusion Criteria
* Breast cancer relapse
* Pregnancy
* Known patent blue allergy
* Indication for radical or partial mastectomy
* Patient unable to understand the trial
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut Cancerologie de l'Ouest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean Marc Classe, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Rene Gauducheau
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospîtal
Angers, , France
Institut Bergonié
Bordeaux, , France
Hospital
Brest, , France
Centre Hospitalier
La Roche-sur-Yon, , France
Centre Oscar Lambret
Lille, , France
centre Léon Berard
Lyon, , France
Institut Paoli Calmette
Marseille, , France
Centre Alexis Vautrin
Nancy, , France
Hospital
Nancy, , France
Hopital Lariboisière
Paris, , France
Hopital Européen Georges Pompidou
Paris, , France
Hôpital Tenon
Paris, , France
Hospital
Poitiers, , France
Institut Jean Godinot
Reims, , France
Centre Eugène Marquis
Rennes, , France
Centre René Gauducheau
Saint-Herblain, , France
Centre Claudius Regaud
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Renaudeau C, Lefebvre-Lacoeuille C, Campion L, Dravet F, Descamps P, Ferron G, Houvenaeghel G, Giard S, Tunon de Lara C, Dupre PF, Fritel X, Ngo C, Verhaeghe JL, Faure C, Mezzadri M, Damey C, Classe JM. Evaluation of sentinel lymph node biopsy after previous breast surgery for breast cancer: GATA study. Breast. 2016 Aug;28:54-9. doi: 10.1016/j.breast.2016.04.006. Epub 2016 May 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BRD 05/11-M
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.